Palexia® PR is indicated for the management of severe chronic pain in adults, which can be adequately managed only with opioid analgesics.1
Confirmed by patients4,6Learn more about consequence
*in severe cLBP with a neuropathic pain component, compared to oxycodone/naloxone PR.
**cumulated number of patients calculated according to the IMS Health, Midas, Consumption Data, Status Q4/2015; providing a DDIs (defined daily intakes) of 2 tablets for prolonged-release formulation and 4 tablets or 2.5ml intakes for immediate release formulations both solid and liquid; duration of treatment of 100 days.
cLBP, chronic lower back pain
PR, prolonged release